Page 37 - Abt News Today

Kavar Capital Partners Group LLC raised its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 1.1% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 49,704 shares of the healthcare product maker’s stock after acquiring an additional 546 shares during the quarter. Kavar […]

Kavar Capital Partners Group LLC increased its position in Abbott Laboratories (NYSE:ABT – Free Report) by 1.1% in the third quarter, HoldingsChannel.com reports. The fund owned 49,704 shares of the healthcare product maker’s stock after buying an additional 546 shares during the period. Kavar Capital Partners Group LLC’s holdings in Abbott Laboratories were worth $4,814,000 […]

Abbott Laboratories (NYSE:ABT – Get Free Report) had its price target increased by investment analysts at Citigroup from $123.00 to $126.00 in a report released on Thursday, Benzinga reports. The firm presently has a “buy” rating on the healthcare product maker’s stock. Citigroup’s target price points to a potential upside of 13.44% from the stock’s […]

Mitchell Capital Management Co. decreased its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 11.5% during the third quarter, HoldingsChannel reports. The fund owned 30,080 shares of the healthcare product maker’s stock after selling 3,921 shares during the quarter. Mitchell Capital Management Co.’s holdings in Abbott Laboratories were worth $2,913,000 as of […]

Amica Retiree Medical Trust lifted its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 29.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 12,738 shares of the healthcare product maker’s stock after purchasing an additional 2,927 shares during the […]

Hamel Associates Inc. raised its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 4.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 19,808 shares of the healthcare product maker’s stock after buying an additional 800 […]

Amica Mutual Insurance Co. raised its position in Abbott Laboratories (NYSE:ABT – Free Report) by 30.8% during the third quarter, according to its most recent filing with the SEC. The institutional investor owned 102,445 shares of the healthcare product maker’s stock after purchasing an additional 24,126 shares during the period. Abbott Laboratories accounts for approximately […]

Netflix adds a record 13 million subscribers in the fourth quarter, AT&T’s earnings miss estimates, Texas Instruments issues a disappointing forecast,...

Abbott Laboratories (NYSE:ABT – Get Free Report) updated its FY24 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of $4.50-4.70 for the period, compared to the consensus estimate of $4.63. Analyst Upgrades and Downgrades Several equities research analysts have issued reports on the stock. TheStreet upgraded shares of Abbott Laboratories from […]

By Will Feuer Abbott Laboratories posted higher sales in the fourth quarter, despite continued soft demand for the company's Covid-19 testing equipment. The...